A subfield of medicine called immunohematology studies how the immune system interacts with blood, specifically the identification of blood cell antigens and associated antibodies. It covers the theories and clinical methods involved in contemporary transfusion therapy. Blood transfusion attempts to save human lives have been documented for several centuries.
Access full Report @ https://www.databridgemarketresearch.com/reports/saudi-arabia-turkey-and-egypt-immunohematology-market
Immunohematology is the study of RBC antigens and antibodies associated with blood transfusions. There are more than 230 types of antigens present on the surface of RBCs which can be used for immunoassay purposes. Immunohematology products include analyzers and reagents used for the analysis of the blood.
For instance,
- According to the WHO, Around 118.5 million units of donated blood are collected globally every year. Their fore analysis of RBC antigens and antibodies becomes an essential part of immunoassays
Data Bridge Market Research analyzes that the Immunohematology Market is expected to grow with a CAGR of 3.8%, 4.2% and 3.0% for Turkey, Saudi Arabia, and Egypt, respectively, in the forecast period of 2023 to 2030. The immunohematology analyzer segment is projected to propel the market growth as there is increasing demand for blood and blood products in Saudi Arabia, Turkey, and Egypt.
Key Findings of the Study
Increasing demand for blood and blood products
Most patients who have a major surgical procedure will have a blood transfusion to replace any blood loss during their surgery. Blood transfusions are used for patients who have experienced serious injuries from car crashes or natural disasters. Individuals with an illness that causes anemia, such as leukemia or kidney disease, will often be the recipients of blood transfusions.
For instance,
- In December 2022, according to the information provided by National Center for Biotechnology Information (NCBI), the forecasted blood donation and dispatch trends suggested a significant increase in blood demand over annual donation rates in Saudi Arabia. In 2020, 342,460 nationwide blood donations were registered in governmental donation centers, and females constituted a mere 2.5%. Approximately 60% of whole blood donation was voluntary, 36% was compensatory, and 4% was part of driving license renewal. The highest blood donation rate per 1,000 inhabitants was observed in Taif (69.8) and Alqonfoda (45.0). Eastern directory and Madinah had the most successful donation campaigns attracting 53% and 50% of total annual donations, respectively. Notably, Tabouk, Hai’l, and Albaha had the highest blood product wastage medians.
Technological advancements for the development of new products. These innovative products have enhanced production efficiency and boosted the manufacturer's credibility in the market. This thus signifies that the rise in strategic acquisition and partnership among organizations is acting as an opportunity for Saudi Arabia, Turkey, and Egypt Immunohematology market growth
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 – 2020)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product Type (Immunohematology Analyzer and Immunohematology Reagent), Technology (Microplates, Gel Cards, Erythrocyte-Magnetized Technology (EMT), Polymerase Chain Reaction and Others), Application (Antibody Screening and Blood Typing), End User (Blood Banks, Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes), Distribution Channel (Direct Sales, Retail Sales and Third Party Distribution)
|
|
Countries Covered
|
Saudi Arabia, Turkey and Egypt
|
|
Market Players Covered
|
Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Ortho Clinical Diagnostics (a Subsidiary of QuidelOrtho Corporation) (Egypt), Merck KGaA. (Germany), Beckman Coulter, Inc. (a Subsidiary of Danaher Corporation) (U.S.), Abbott (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and HORIBA (Japan) among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
The Saudi Arabia, Turkey, and Egypt Immunohematology market is categorized into five notable segments, which are based on products type, technology, application, end user, and distribution channel.
- On the basis of products type, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into immunohematology analyzer and immunohematology reagent. In 2023, the immunohematology analyzer segment is expected to dominate the Saudi Arabia, Turkey, and Egypt immunohematology market with a 72.72%, 75.99% and 77.87% market share for Turkey, Saudi Arabia and Egypt respectively in the forecast period of 2023 to 2030.
In 2023, the immunohematology analyzer market segment dominating in the Saudi Arabia, Turkey, and Egypt immunohematology market due to the rising awareness about blood donation across Saudi Arabia, Turkey, and Egypt.
- On the basis of technology, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into microplates, gel cards, polymerase chain reaction, eryhtrocyte-magnetized technology (EMT) and others. In 2023, the microplates segment is expected to dominate the Turkey, Saudi Arabia and Egypt immunohematology market with a 28.59%, 37.14% and 44.67% market share for Turkey, Saudi Arabia and Egypt respectively in the forecast period of 2023 to 2030.
- On the basis of application, the Turkey, Saudi Arabia, and Egypt immunohematology market is segmented into blood typing and antibody screening. In 2023, the blood typing segment is expected to dominate the Turkey, Saudi Arabia, and Egypt immunohematology market with a 57.67%, 58.75% and 60.73% market share for Turkey, Saudi Arabia and Egypt in the forecast period of 2023 to 2030.
- On the basis of end user, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into blood banks, hospitals, diagnostic and reference laboratories and academic and research institutes. In 2023, the blood banks segment is expected to dominate the Saudi Arabia, Turkey, and Egypt immunohematology market with 39.11%, 46.43% and 52.85% market share for Turkey, Saudi Arabia and Egypt respectively in the forecast period of 2023 to 2030.
- On the basis of distribution channel, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into direct sales, third party distribution and retail sales. In 2023, the direct sales segment is expected to dominate the Saudi Arabia, Turkey, and Egypt immunohematology market with 48.31%, 54.50% and 59.97% market share for Turkey, Saudi Arabia and Egypt respectively in the forecast period of 2023 to 2030.
Major Players
Data Bridge Market Research recognizes the following companies as the market players in the Saudi Arabia, Turkey, and Egypt immunohematology market that include Siemens Healthineers AG, Thermo Fisher Scientific Inc. ,Ortho Clinical Diagnostics (a Subsidiary of QuidelOrtho Corporation) , Merck KGaA. ,Beckman Coulter, Inc. (a Subsidiary of Danaher Corporation), Abbott , Bio-Rad Laboratories, Inc. and HORIBA among others.
Market Development
- In March 2023, Abbott announced a definitive agreement with Cardiovascular Systems, Inc. (CSI), a manufacturer of medical devices with a cutting-edge atherectomy system used to treat peripheral and coronary artery disease, under which Abbott would purchase CSI. Abbott's market-leading vascular device lineup will gain access to fresh, complementary innovations thanks to the purchase of CSI. This has caused the business to grow for the corporation.
- In October 2022, Thermo Fisher Scientific Inc. announced that it is going to expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development.
- In February 2023, Siemens Healthineers and Unilabs signed a multi-year partnership worth over €200 million with leading providers of diagnostic services. Unilabs has invested in cutting-edge Siemens Healthineers technology and will buy more than 400 laboratory analyzers to further enhance its laboratory infrastructure and provide customers with unmatched service.
- In August 2023, Bio-Rad Laboratories, Inc. announced that the company acquired Scope Fluidics, S.A., a Warsaw, Poland-based developer of cutting-edge technology solutions for the medical diagnostic and healthcare markets, has agreed to sell all of Curiosity Diagnostics, Sp. Z. o.shares to Bio-Rad Laboratories, Inc. for a total consideration of up to USD 170 million (consisting of roughly USD 100 million in cash and up to USD 70 million in potential future milestone payments). A sample-to-answer, rapid diagnostics PCR system is being developed by Curiosity Diagnostics, a late-stage, pre-commercial platform firm, for the molecular diagnostics market. This prompted the company to grow its clientele.
- In November 2020, after receiving all required regulatory and antitrust permissions, Werfen announced that the acquisition of Immucor, Inc., had been completed. Immucor is a privately held in vitro diagnostics (IVD) firm with a strong global presence in the transfusion and transplant sectors. It is situated in the US. This has aided the company in expanding its product offerings around the world.
- In July 2023, Beckman Coulter, Inc. announced a partnership with Scopio in order to hasten the deployment of their most recent platforms for peripheral blood smears. In order to completely replace manual microscopy, Scopio's technology uses Full-Field imaging and AI decision support while offering laboratory workers and doctors a genuine workflow boost. The Scopio systems streamline lab operations and enhance workflow in a distributed network with easy-to-use remote viewing. No longer must slides be sent between locations; high quality full-field images may now be transmitted in real time across a secure hospital network. This has aided the corporation in using modern technology to grow its operations.
Regional Analysis
Geographically, the countries covered in the immunohematology market report are Saudi Arabia, Egypt and Turkey.
As per Data Bridge Market Research analysis:
Turkey is the dominant region in Saudi Arabia, Turkey, and Egypt immunohematology market during the forecast period 2023-2030
In 2023, Turkey dominates the Saudi Arabia, Turkey, and Egypt immunohematology market owing to the increasing incidence of trauma and immunohematological disorders. Turkey will continue to dominate the Saudi Arabia, Turkey, and Egypt immunohematology market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising awareness about blood donation in this region. Additionally, the technological advancements for the development of new products in the country are expected to further enhance the market's growth rate in this region.
Saudi Arabia is estimated to be the fastest growing region in Saudi Arabia, Turkey, and Egypt immunohematology market in the forecast period 2023-2030
Saudi Arabia is expected to grow during the forecast period due to the presence of major market players and the rapid development of medical facilities in emerging economies in this region. In addition to this, rising awareness about blood donation and blood cancer propels the market's growth rate in this region.
COVID-19 Impact Analysis
The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to grow mainly due to factors such as a sharp rise in market demand for PCR, NGS, serology-based rapid-test products, the supportive regulatory landscape for product development & commercialization, and a sharp rise in target patient population. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities as well as to focus on product commercialization & upgrade.
For more detailed information about the immunohematology market report, click here – https://www.databridgemarketresearch.com/reports/saudi-arabia-turkey-and-egypt-immunohematology-market
